| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,231 |
11,278 |
$836K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
4,540 |
4,514 |
$432K |
| 99233 |
Prolong inpt eval add15 m |
6,634 |
2,071 |
$416K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
2,107 |
2,049 |
$383K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
2,090 |
2,029 |
$327K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,807 |
2,798 |
$266K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,338 |
4,985 |
$235K |
| J2785 |
Injection, regadenoson, 0.1 mg |
1,562 |
1,505 |
$219K |
| 99223 |
Prolong inpt eval add15 m |
2,006 |
1,920 |
$211K |
| 93458 |
|
829 |
819 |
$124K |
| 93970 |
|
799 |
795 |
$87K |
| 93015 |
|
2,289 |
2,228 |
$66K |
| 93000 |
|
7,348 |
7,224 |
$62K |
| 93979 |
|
807 |
802 |
$55K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
740 |
245 |
$31K |
| 93880 |
|
242 |
242 |
$27K |
| 93923 |
|
709 |
701 |
$18K |
| 93925 |
|
119 |
119 |
$16K |
| 93351 |
|
116 |
115 |
$16K |
| 99457 |
|
441 |
441 |
$13K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
2,107 |
2,067 |
$10K |
| 99454 |
|
264 |
264 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
112 |
112 |
$7K |
| 93244 |
|
440 |
438 |
$6K |
| 93227 |
|
333 |
333 |
$4K |
| 93225 |
|
335 |
335 |
$4K |
| 93298 |
|
161 |
161 |
$3K |
| 93242 |
|
441 |
437 |
$3K |
| 93971 |
|
38 |
36 |
$3K |
| 93978 |
|
24 |
24 |
$3K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
143 |
143 |
$3K |
| 99221 |
|
28 |
28 |
$2K |
| 99220 |
|
12 |
12 |
$1K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
39 |
39 |
$824.60 |
| 99406 |
|
67 |
66 |
$539.05 |
| J0280 |
Injection, aminophyllin, up to 250 mg |
53 |
53 |
$326.41 |
| 93922 |
|
13 |
13 |
$178.26 |
| 99156 |
|
15 |
14 |
$177.48 |
| 99453 |
|
12 |
12 |
$137.34 |
| J7050 |
Infusion, normal saline solution, 250 cc |
37 |
37 |
$22.85 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
3,794 |
3,574 |
$0.82 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
1,609 |
1,550 |
$0.15 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
10,295 |
9,256 |
$0.10 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
4,181 |
3,956 |
$0.02 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
3,896 |
3,685 |
$0.01 |
| 1036F |
|
2,203 |
2,121 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
560 |
537 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
409 |
383 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
30 |
29 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
930 |
906 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
897 |
854 |
$0.00 |
| G8598 |
Aspirin or another antiplatelet therapy used |
140 |
135 |
$0.00 |
| 4004F |
|
51 |
48 |
$0.00 |